The statin-low cholesterol-cancer conundrum.

@article{Ravnskov2012TheSC,
  title={The statin-low cholesterol-cancer conundrum.},
  author={Uffe Ravnskov and Kilmer S. Mccully and Paul J. Rosch},
  journal={QJM : monthly journal of the Association of Physicians},
  year={2012},
  volume={105 4},
  pages={
          383-8
        }
}
Hundreds of millions of people all over the globe are currently being administered statins because it is believed that their lipid lowering actions provide cardioprotective benefits. Adverse effects are considered uncommon and mild, and authors of numerous case–control studies of patients on statin treatment and matched, untreated individuals have even suggested a protective effect against numerous non-cardiovascular diseases, including cancer. In contrast, four controlled, randomized statin… 

Tables from this paper

STATIN ADVERSE EFFECTS: MECHANISMS, DIAGNOSIS, PREVENTION AND MANAGEMENT
TLDR
The purpose of this review was to systemize the most frequent statin adverse effects, including mechanisms, diagnosis, treatment and prevention, and to provide a larger prospective randomized placebo-controlled trials with a long follow-up.
Statin use and reduced cancer-related mortality.
TLDR
The lack of a dose–response effect in their study further supports the hypothesis that smoking is a strong risk factor for fracture, pneumonia, and cancer-related death, and may have led to an inverse association between statin use and the risk of cancer- related death in the observational study by Nielsen and colleagues.
The Spectrum of Statin Therapy in Cancer Patients: Is There a Need for Further Investigation?
  • M. Gonyeau
  • Medicine, Biology
    Current Atherosclerosis Reports
  • 2013
TLDR
Clinical trials investigating the relationship between cancer and statin use should consider three main end products of the mevalonate pathway from a mechanistic perspective, as well as the potential for cancer cell mediation withstatin use, in addition to pertinent clinical end points including cancer incidence and mortality.
LDL-C does not cause cardiovascular disease: a comprehensive review of the current literature
TLDR
The search for falsifications of the cholesterol hypothesis confirms that it is unable to satisfy any of the Bradford Hill criteria for causality and that the conclusions of the authors of the three reviews are based on misleading statistics, exclusion of unsuccessful trials and by ignoring numerous contradictory observations.
Biochemical risk factors of atherosclerotic cardiovascular disease: from a narrow and controversial approach to an integral approach and precision medicine
TLDR
The current approach of management of dyslipidemias and CVD prevention is evaluated to find modern alternatives for more precise diagnosis and therapy of Dyslipidemic patients to realize precision diagnostics and precision medicine.
Statins and the Risk of Cirrhosis in Chronic Hepatitis B Patients
  • Yu-wen Hu
  • Medicine
    The American Journal of Gastroenterology
  • 2016
TLDR
The statins cohort comprised of 4,188 adult patients with 1:1 ratio propensity score, and inceptionpoint-matched patients in non-statins cohort were comparable on age, gender, hypertension, obesity, chronic hepatitis B (CHB) treatment, and follow-up years for cirrhosis and decompensated Cirrhosis.
Statin use and reduced cancer-related mortality.
TLDR
The reduced cancer-related mortality among statin users as compared with those who had never used statins was observed for each of 13 cancer types, suggesting a need for trials of statins in patients with cancer.
Lipid-lowering drugs, dyslipidemia, and breast cancer risk in a Medicare population
TLDR
The data do not support using statins or other lipid-lowering drugs to prevent breast cancer and dyslipidemia was associated with greater reductions in risk for later stage than earlier stage breast cancer (p-heterogeneity < 0.0001).
...
...

References

SHOWING 1-10 OF 56 REFERENCES
Low plasma cholesterol predicts an increased risk of lung cancer in elderly women.
TLDR
Both men and women with baseline plasma cholesterol levels < 160 mg/dl were more likely to die of lung cancer, and the association could not be explained by occult malignancy, smoking, or socioeconomic status.
EFFECT OF STATIN USE ON BIOCHEMICAL OUTCOME FOLLOWING RADICAL PROSTATECTOMY
TLDR
This study shows no benefit and possible worse biochemical outcome after radical prostatectomy and agrees with the findings that statin users may have lower PSA than non-users.
Adherence with statin therapy in elderly patients with and without acute coronary syndromes.
Cholesterol-lowering and cancer in the prevention of cardiovascular disease.
  • M. Oliver
  • Medicine
    QJM : monthly journal of the Association of Physicians
  • 2010
TLDR
The worrying results of the first major primary prevention cholesterol-lowering trial using another drug should not be forgotten and the WHO Clofibrate Trial, of which I was a consultant, should be forgotten.
Carcinogenicity of lipid-lowering drugs.
TLDR
Evidence of carcinogenicity of lipid-lowering drugs from clinical trials in humans is inconclusive because of inconsistent results and insufficient duration of follow-up, and the results of experiments in animals and humans suggest that lipid- Lowering drug treatment should be avoided except in patients at high short-term risk of coronary heart disease.
Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia.
TLDR
A reasonable strategy to prevent coronary events in Japanese hypercholesterolemic patients without prior CHD under low-dose statin treatment might be regulating the serum lipid concentrations to at least <240 mg/dl for TC, <160 mg/DL for LDL-C, <300 mg/dam for TG, and >40 mg/dn for HDL-C.
Statin use and risk of prostate cancer: results from a population-based epidemiologic study.
TLDR
Althoughstatin use was not associated with overall prostate cancer risk, the finding of an increased risk associated with statin use among obese men, particularly use for extended durations, warrants further investigation.
...
...